Virax Biolabs(VRAX) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

12 Health Care Stocks Moving In Friday's After-Market Session
BenzingaApr 11 17:06 ET
H.C. Wainwright Initiates Virax Biolabs(VRAX.US) With Buy Rating, Announces Target Price $3
Moomoo NewsMar 31 17:31 ET · Ratings
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
BenzingaMar 31 14:57 ET
HC Wainwright & Co. Initiates Coverage On Virax Biolabs Group With Buy Rating, Announces Price Target of $3
BenzingaMar 31 07:00 ET · Ratings
Virax Biolabs Group Analyst Ratings
BenzingaMar 31 06:58 ET · Ratings
Express News | Virax Biolabs Enrolls First Patients In Its UK Based Clinical Study Assessing T Cell Dysfunction In Post-acute Infection Syndromes
BenzingaMar 18 07:30 ET

Comments

Teddy123

Mar 18 19:39

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

$Virax Biolabs (VRAX.US)$
Breakthrough T Cell Study: Virax Targets Long COVID and Chronic Fatigue Diagnosis Revolution

Trytosaveabit

Mar 18 19:31

news

$Virax Biolabs (VRAX.US)$ Benzinga· just
Virax Biolabs Enrolls First Patients In Its UK Based Clinical Study Assessing T Cell Dysfunction In Post-acute Infection Syndromes

1

Teddy123

Mar 13 19:35

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

$Virax Biolabs (VRAX.US)$
Game-Changing Long COVID Diagnostic: Virax's New T-Cell Test Shows Promising Results

Jaguar8

Mar 13 19:30

NEWS

$Virax Biolabs (VRAX.US)$
Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
Thursday, 13th March at 7:30 am
LONDON, March 13, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced it has presented data evaluating the role of T-Cell dysfunction in pos...

2